Journal article
Advances in the treatment of Raynaud's phenomenon
Vascular health and risk management, Vol.6(1), pp.167-177
03/24/2010
Handle:
https://hdl.handle.net/2376/107992
PMID: 20448801
Abstract
Raynaud's phenomenon is a common condition characterized by vasospasm of the digital arteries and resulting cyanosis and redness. It often does not require pharmacologic management, but in some cases symptoms are severe and pharmacologic management is necessary. Calcium channel blockers are often used first-line, but in some patients are ineffective. Patients with severe symptoms or intolerance to available therapies have prompted exploration of alternative therapies, including endothelin antagonists, phosphodiesterase-5 inhibitors, antioxidants, newer vasodilators, statins, and botulinum toxin. These newer therapies provide the focus for this review.
Metrics
7 Record Views
Details
- Title
- Advances in the treatment of Raynaud's phenomenon
- Creators
- Terri L Levien - College of Pharmacy, Washington State University Spokane, WA, USA. levient@wsu.edu
- Publication Details
- Vascular health and risk management, Vol.6(1), pp.167-177
- Academic Unit
- Pharmacotherapy, Department of
- Publisher
- New Zealand
- Identifiers
- 99900547248801842
- Language
- English
- Resource Type
- Journal article